Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE: Patiromer for RAAS Optimization in Chronic Kidney Disease
NCT06256991Phase 4Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of patiromer in chronic kidney disease (CKD), hyperkalemia, sponsored by University Medical Center Groningen. Started Apr 2024; status: recruiting.
02
Drugs
patiromer
03
Conditions
chronic kidney disease (CKD)hyperkalemia
Beyond the preview
Go deeper on NCT06256991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06256991.